Jardiance
by Boehringer Ingelheim
Jardiance (empagliflozin) is prescribed to lower blood sugar levels in Type II diabetics. Between 90 and 95% of the more than 30 million diabetics in the U.S. have Type II diabetes.
Jardiance (empagliflozin) is prescribed to lower blood sugar levels in Type II diabetics. Between 90 and 95% of the more than 30 million diabetics in the U.S. have Type II diabetes.
Patient assistance programs
Jardiance Patient Assistance Program
Manufacturer PAP- Eligibility
- Patients who meet income and insurance requirements
- Income limit
- Varies — contact ClariMeds for current limits
- Insurance
- Typically uninsured or underinsured; Medicare/Medicaid restrictions may apply
- How to apply
- Apply through ClariMeds — we handle the paperwork at no cost
Need help applying?
ClariMeds handles the entire application process for you — for free. See if you qualify in minutes.
See If You Qualify — Free